QA: Axsome Therapeutics Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001579428_2020_Axsome_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001579428, Axsome Therapeutics Inc

  xvar xval
0 AssetsCurrent 220,379,262
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 30,623
3 remainder_Assets 139,875
4 LiabilitiesCurrent 24,494,745
5 LiabilitiesNoncurrent 17,332,626
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,977,346
9 ResearchAndDevelopmentExpense 59,553,921
10 remainder_Expenses -2,524,036
11 remainder_Revenues 0
12 remainder_NetIncome -1,047,940
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 220,549,760
1 Liabilities 41,827,371
2 Expenses 73,007,231
3 Revenues 0
4 StockholdersEquity 178,722,389
5 NetIncome -74,055,171
6 ComprehensiveNetIncome -74,055,171
7 BaseVar 168,216,151
8 EconomicCapitalRatiobeforeLimitedLiability 2.41
9 EconomicCapitalRatio 3.29

Edgar->Model Mapping

Feature Distribution

Change over Time